Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07040189 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders

Study acronym: GustaborPilot
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 31, 2025 → Dec 31, 2026
See other at-risk trials from Wuerzburg University Hospital

Record History

  1. Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Recruitment opened
    • Start date changed from estimate of Aug 1, 2025 to Nov 25, 2025
    • Site details revised at 3 of 3 sites
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment discontinuation. Although many non-pharmacological recommendations exist, it is unclear which methods are suitable for which individuals. This pilot study aims to use an AI-based, or rule-driven system to generate personalized recommendations based on patients' specific impairments and taste disorder. For the pilot study, the AI will be trained on recipes to create individualized meal plans, helping to identify foods that are likely to be better. The primary endpoint is the assessment of the nutritional intervention as helpful at the second visit within 12 weeks of inclusion.
Trial Details
NCT Number NCT07040189
Lead Sponsor Wuerzburg University Hospital
Collaborators: LMU Klinikum, University Hospital Regensburg
Conditions
(from sponsor)		 Multiple Myeloma, GI Cancer, Taste Disorders
Related terms Gastrointestinal Neoplasms, Multiple Myeloma, Taste Disorders
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov